Skip to content
Search

Latest Stories

Welsh Pharmacy Service Helps 1.25M People with Common Ailments Since 2013, Reducing GP Burden

400,000 pharmacy visits as Welsh Gov invests £9.9M in service Common ailments
Over 400,000 pharmacy visits for common ailments as the Welsh Government invests an additional £9.9M this year to expand the common ailments service across Wale

Almost all pharmacies in Wales provide free advice and treatment for 28 common ailments, helping reduce GP appointments significantly  

The common ailments service, available in 99 per cent of pharmacies throughout Wales, has helped almost 1.25 million people since its launch in 2013, according to a government release.

Last year, more than 400,000 people used the service, which provides access to free, confidential advice and treatments for 28 common illnesses, including sore throats and urinary tract infections.


The Welsh government has backed this service expansion with substantial funding, increasing its investment by 24 per cent since 2016 to 2017, with an additional £9.9 million this year.

Health secretary Jeremy Miles has urged people to visit local pharmacies for minor ailments to help to free up GP appointments for people with more complex or urgent health issues.

Miles said: “We know there is very high demand for GP services in Wales, with around 1.6 million people contacting their practice each month.

“For most common health concerns, your local pharmacy is the best option, providing free and easy access to treatment.”

He also revealed the government is working with the NHS to provide more care in the community, closer to people’s homes.

Gwawr Davies-Jones, a pharmacist at High Street Pharmacy, Barry, emphasized that their role has changed considerably since the implementation of the new pharmacy contract in 2022.

“Instead of being in the dispensary, we are now in the consultation room for the most part of the day, offering clinical services,” she said.

She revealed that on average they undertake more than 20 consultations every day, ranging from providing contraception to emergency medicine supplies.

“We feel we offer an invaluable service to our community. The services we offer alleviate pressures on the NHS, providing great satisfaction to pharmacists knowing that they are doing their bit,” Gwawr added.

In addition to common ailments service, many Welsh pharmacies offer emergency contraception, annual flu vaccinations and regular contraception services.

Currently, around 220 pharmacies – equivalent to a third of all pharmacies in Wales – are also delivering the pharmacist independent prescribing service.

This enables pharmacists to treat a range of conditions such as ear, skin and respiratory infections, sinusitis and migraine.

Most people (95 per cent) who visited pharmacies for common conditions said that they would have otherwise visited their GP or other healthcare provider, had they not been able to access this service.

Furthermore, the official statement mentioned that around 100 community pharmacists are undertaking prescribing training every year in Wales.

From 2026, all newly qualified pharmacists will be prescribers at the point of registration.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less